BOBULSKY SUSAN
SEC CIK 1820885 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | Chief Commercial Off, MRD | 395.8K | — | $1.43M | 15 | 2024-03-04 | 2026-09-15 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-17 18:50 | 2026-09-15 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $27.00 | -1,195 | 395.8K | -0.3% | -$32.3K |
| T | 2026-08-12 19:33 | 2026-08-10 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $25.00 | -3,000 | 397.0K | -0.8% | -$75.0K |
| T | 2026-08-03 18:26 | 2026-07-30 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $24.00 | -1,299 | 400.0K | -0.3% | -$31.2K |
| T | 2026-07-20 19:19 | 2026-07-16 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $23.00 | -5,000 | 401.3K | -1% | -$115.0K |
| T | 2026-07-06 19:15 | 2026-07-01 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $22.00 | -487 | 406.3K | -0.1% | -$10.7K |
| T | 2026-06-29 19:52 | 2026-06-25 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $20.50 | -5,000 | 406.8K | -1% | -$102.5K |
| T | 2026-06-15 19:13 | 2026-06-11 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $19.00 | -5,000 | 411.8K | -1% | -$95.0K |
| T | 2026-06-08 20:27 | 2026-06-04 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $18.00 | -11.0K | 416.8K | -3% | -$198.0K |
| 2026-03-13 | 2026-03-11 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $13.17 | -41.3K | 427.8K | -9% | -$544.4K | |
| M | 2026-03-06 | 2026-03-04 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +121.9K | 406.6K | +43% | $0 |
| D | 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +120.0K | 373.3K | +47% | $0 |
| D | 2025-03-06 | 2025-03-05 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $6.98 | -26.0K | 347.2K | -7% | -$181.6K |
| D | 2024-10-10 | 2024-10-08 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | M - OptEx | $1.98 | +5,000 | 253.3K | +2% | +$9,900 |
| DM | 2024-03-06 | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $3.44 | -13.0K | 255.3K | -5% | -$44.6K |
| D | 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +133.0K | 261.3K | +104% | $0 |
Purchase Sale Sale after option exercise All abbreviations